 | Up a level |
Wu, Yi-Long and Guarneri, Valentina and Voon, Pei Jye and Lim, Boon Khaw and Yang, Jin-Ji and Wislez, Marie and Huang, Cheng and Liam, Chong Kin and Mazieres, Julien and Tho, Lye Mun and Hayashi, Hidetoshi and Nhung, Nguyen Viet and Chia, Puey Ling and de Marinis, Filippo and Raskin, Jo and Zhou, Qinghua and Finocchiaro, Giovanna and Le, Anh Tuan and Wang, Jialei and Dooms, Christophe and Kato, Terufumi and Nadal, Ernest and Hin, How Soon and Smit, Egbert F. and Wermke, Martin and Tan, Daniel and Morise, Masahiro and O'Brate, Aurora and Adrian, Svenja and Pfeiffer, Boris M. and Stroh, Christopher and Juraeva, Dilafruz and Strotmann, Rainer and Goteti, Kosalaram and Berghoff, Karin and Ellers-Lenz, Barbara and Karachaliou, Niki and Le, Xiuning and Kim, Tae Min and INSIGHT investigators, - (2024) Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial. Lancet Oncology, 25 (8). pp. 989-1002. ISSN 1470-2045, DOI https://doi.org/10.1016/S1470-2045(24)00270-5.
Lim, Sun Min and Tan, Jiunn-Liang and Dias, Josiane Mourao and Voon, Pei Jye and How, Soon Hin and Zhou, Xiangdong and Xiong, Hailin and Massuti, Bartomeu and Medley, Louise C. and Nagasaka, Misako and Vicente, David and Girard, Nicolas and Rittmeyer, Achim and Botesteanu, Dana-Adriana and Alhadab, Ali and Mahoney, Janine M. and Zhang, Jie and Bauml, Joshua Michael and Baig, Mahadi and Scott, Susan Combs (2024) Subcutaneous amivantamab and lazertinib as first-line treatment in patients with <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Results from the phase 2 PALOMA-2 study. Journal of Clinical Oncology, 42 (17_SUP). LBA8612. ISSN 0732-183X, DOI https://doi.org/10.1200/JCO.2024.42.17_suppl.LBA8612.
Yoon, Sook-Yee and Wong, Siu Wan and Lim, Joanna and Ahmad, Syuhada and Mariapun, Shivaani and Padmanabhan, Heamanthaa and Hassan, Nur Tiara and Lau, Shao Yan and Ch'ng, Gaik-Siew and Haniffa, Muzhirah and Ong, Winnie P. and Rethanavelu, Kavitha and Moey, Lip Hen and Keng, Wee Teik and Omar, Jamil and Mohd Abas, Mohd Norazam and Yong, Chee Meng and Ramasamy, Vickneswaren and Md Noor, Mohd Rushdan and Aliyas, Ismail and Lim, Michael C. K. and Suberamaniam, Anuradha and Mat Adenan, Noor Azmi and Ahmad, Zatul Akmar and Ho, Gwo Fuang and Abdul Malik, Rozita and Subramaniam, Suguna and Khoo, Boom Ping and Raja, Arivendran and Chin, Yeung Sing and Sim, Wee Wee and Teh, Beng Hock and Kho, Swee Kiong and Ong, Eunice S. E. and Voon, Pei Jye and Ismail, Ghazali and Lee, Chui Ling and Abdullah, Badrul Zaman and Loo, Kwong Sheng and Lim, Chun Sen and Lee, Saw Joo and Lim, Keng Joo Lim and Shafiee, Mohamad Nasir and Ismail, Fuad and Latiff, Zarina Abdul and Ismail, Mohd Pazudin and Mohamed Jamli, Mohamad Faiz and Kumarasamy, Suresh and Leong, Kin Wah and Low, John and Md Yusof, Mastura and Ahmad Mustafa, Ahmad Muzamir and Mat Ali, Nor Huda and Makanjang, Mary and Tayib, Shahila and Cheah, Nellie and Lim, Boon Kiong and Fong, Chee Kin and Foo, Yoke Ching and Mellor Abdullah, Matin and Tan, Teck Sin and Chow, Doris S. Y. and Ho, Kean Fatt and Raman, Rakesh and Radzi, Ahmad and Deniel, Azura and Teoh, Daren C. Y. and Ang, Soo Fan and Joseph, Joseph K. and Ng, Paul Hock Oon and Tho, Lye-Mun and Ahmad, Azura Rozila and Muin, Ileena and Bleiker, Eveline and George, Angela and Thong, Meow-Keong and Woo, Yin Ling and Teo, Soo Hwang (2022) Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes. Journal of Medical Genetics, 59 (3). pp. 220-229. ISSN 0022-2593, DOI https://doi.org/10.1136/jmedgenet-2020-107416.
Tang, Ing Ping and Ngui, Ling Xiu and Ramachandran, Komathi and Lim, Li Yun and Voon, Pei Jye and Yu, Kong Leong and Narayanan, Prepageran and Carrau, Ricardo (2019) A 4-year review of surgical and oncological outcomes of endoscopic endonasal transpterygoid nasopharyngectomy in salvaging locally recurrent nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology, 276 (9). pp. 2475-2482. ISSN 0937-4477, DOI https://doi.org/10.1007/s00405-019-05522-5.
